Studies have proved that eIF4A3 regulates tumor cell function and drug resistance by regulating the TNF-α/NF-kB signaling pathway [23], whether this signaling pathway was involved ineIF4A3-regulated GC carcinogenesis needs further investigation. The gene discussed is NFKB1; the disease is neoplasm.